Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Loestrin (norethindrone acetate and ethinyl estradiol)[4] Acetate,
Estradiol (Estradiol / Norethindrone Acetate),
Ethinylestradiol (Norethindrone Acetate and Ethinyl Estradiol),
Norethisterone (Norethindrone Acetate and Ethinyl Estradiol)		[3] Estradiol ,
Norethindrone ,
Ethinyl estradiol 💬 		[3] ESR1,
ESR2,
PGR 💬 		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 299 💬
2Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)[4] Acetate,
Estradiol (Estradiol / Norethindrone Acetate),
Ethinylestradiol (Norethindrone Acetate and Ethinyl Estradiol),
Norethisterone (Norethindrone Acetate and Ethinyl Estradiol)		[3] Estradiol ,
Norethindrone ,
Ethinyl estradiol 💬 		[3] ESR1,
ESR2,
PGR 💬 		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[2] 46, 49 💬
3Norethindrone[1] Norethisterone (Norethindrone Acetate and Ethinyl Estradiol)[1] Norethindrone 💬 [1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[4] 13, 46, 49, 299 💬